4
Changes in Ownership
Nuvation Bio Inc. Filed Acc 0001415889-24-022899
Director acquired 19,004,200 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Cui Xiangmin · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-09-04 | Conversion : show line 1 in the form | +967,100 | 1,281,206 | I |
| 2024-09-04 | Conversion : show line 2 in the form | +5,157,900 | 7,611,031 | I |
| 2024-09-04 | Conversion : show line 3 in the form | +12,879,200 | 17,062,202 | I |
Table II: Derivative
9 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-09-03 | Grant or award : show line 4 in the form Series A Preferred Stock | +9,671 | 9,671 | I |
| 2024-09-03 | Grant or award : show line 5 in the form Series A Preferred Stock | +51,579 | 51,579 | I |
| 2024-09-03 | Grant or award : show line 6 in the form Series A Preferred Stock | +128,792 | 128,792 | I |
| 2024-09-03 | Grant or award : show line 7 in the form Warrants (Right to Buy) | +32,877 | 32,877 | I |
| 2024-09-03 | Grant or award : show line 8 in the form Warrants (Right to Buy) | +175,346 | 175,346 | I |
| 2024-09-03 | Grant or award : show line 9 in the form Warrants (Right to Buy) | +437,834 | 437,834 | I |
| 2024-09-04 | Conversion : show line 10 in the form Series A Preferred Stock | −9,671 | 0 | I |
| 2024-09-04 | Conversion : show line 11 in the form Series A Preferred Stock | −51,579 | 0 | I |
| 2024-09-04 | Conversion : show line 12 in the form Series A Preferred Stock | −128,792 | 0 | I |
Loading xslF345X05/form4-09052024_040901.xml…